Collection & Ordering

How it works

Percepta GSC fits seamlessly into your current lung cancer diagnostic
bronchoscopy protocol.
Scientific illustration of lungs with a close up of a bronchoscopy brushing lung tissue.

1. Collect patient samples

2 brushings (8-10 passes each) from
the normal-appearing right main
stem bronchus

Photo of an open Veractye Nanocool Sample collection box

2. Ship to Veracyte

Veracyte provides sample collection
kit and FedEx shipping from collection
site to Veractye lab.

A smart phone showing test results in the Veracyte mobile app

3. Online results

Confirm order if bronchoscopy is
inconclusive. Results will be delivered
within two weeks on the Veracyte
online portal and mobile app.

Play Video

Percepta GSC collection and reporting

During a bronchoscopy procedure, cells are collected from the right main stem bronchus using a cytology brush. In the event a bronchoscopy is inconclusive you may order Percepta GSC.

Who is a good candidate for Percepta GSC?

Logo of a clipboard showing inconclusive results
Clinical factors:
Inconclusive bronchosopy
Smoking logo
Patient:
Current or former smokers and over 21 years of age
No Cancer logo
Cancer history:
No concurrent or prior cancer

Result interpretation

Percepta GSC stratifies the risk of primary lung cancer across all pre-test risk groups to guide patient management when bronchoscopy is inconclusive.

Representation of an intermediate risk of malignancy, as assessed pre-bronchoscopy by a physician, to low risk after Percepta test.
Percepta GSC can down-classify the risk of primary lung cancer for intermediate pre-test risk patients.
Representation of an intermediate risk of malignancy, as assessed pre-bronchoscopy by a physician, to high risk after Percepta test.
Percepta GSC can up-classify the risk of primary lung cancer for intermediate pre-test risk patients.

Viewing test reports

Test results delivered within two weeks to your computer or phone.

A smart phone showing the test results for a Percepta GSCtest. In the example, the test is reclassified to low risk.

View your Veracyte portal to get practice insights, track trends, and better understand your patients. Your Home Dashboard illustrates:

  • Samples submitted and status report (Reported / Processing / Not Ordered)
  • Order history
  • Result breakdown by test result. Patient results are available within two weeks.
 

If you want to learn more or would like a walk through of your dashboard please contact our customer care team at 844.464.LUNG (844.464.5864) or support@veracyte.com.

Access practice trend reports and sample testing status​

Covered by Medicare

The Percepta GSC  test is covered by Medicare. Veracyte bills Medicare and third-party payers directly.

 

The Veracyte Access Program provides financial support for both eligible uninsured and commercially available insured patients with financial need.

Frequently Asked Questions

Results for the Percepta Genomic Sequencing Classifier are available within two weeks after the test order is confirmed.

Results can be accessed on the Veracyte online portal and mobile app.

Samples should be packaged and shipped to Veracyte on the same day as collected, using the provided shipper and return shipping labels.

Samples should be shipped the same day via FedEx®. Return label is pre-applied to the provided shipping box. If you do not have a routine pickup, call FedEx at 1.800.GOFEDEX (1.800.463.3339) to schedule one.